BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

Reuters

02-28

BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

Feb 28 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY:

UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER
UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV

Source text: [ID:]

Further company coverage: MRNA.O

((Reuters.Briefs@thomsonreuters.com;))

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2514901344"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2514901344\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2514901344?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-28 18:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2514901344","market":"us","top_or_hot":-1,"title":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over</title></head><body><p><span>Feb 28 (Reuters)</span><span> - </span>MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: </p><ul><li><p>UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER</p></li><li><p>UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: <span>MRNA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-02-28 18:37</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<title>BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over</title><p><span>Feb 28 (Reuters)</span><span> - </span>MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: </p><ul><li><p>UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER</p></li><li><p>UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV</p></li></ul><p>Source text: [ID:]</p><p>Further company coverage: <span>MRNA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4551","symbol_name":"寇图资本持仓","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ0VV:1","article_id":"2514901344","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2514901344","pubTimestamp":1740739049,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And OverFeb 28  - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVERUK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSVSource text: [ID:]Further company coverage: MRNA.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4551":"寇图资本持仓","MRNA":"Moderna, Inc.","BK4548":"巴美列捷福持仓","BK4585":"ETF&股票定投概念","BK4501":"段永平概念","BK4534":"瑞士信贷持仓","BK4588":"碎股","BK4139":"生物科技","BK4568":"美国抗疫概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4532":"文艺复兴科技持仓"},"translate_title":"简报-英国MHRA表示mRESVIA RSV疫苗获准保护60岁及以上患者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And OverFeb 28 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY: UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVERUK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSVSource text: [ID:]Further company coverage: MRNA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}